PRODUCT CENTER

产品中心

Location:Product > Probiotics

CSL is one of the world's first companies to research and validate the efficacy of probiotics (lactic acid bacteria on the intestinal ecosystem and immune system) with a strong research background and literature support, has published more than 300 probiotic research papers and the human clinical trial reports, has a number of patents for probiotic bacteria.


小气泡.png  Probiotics with different functions: intestinal health, immune health, oral health, vaginal health, cardiovascular health, skin health, infant health

小气泡.png  More than 300 probiotic research papers and human clinical trial reports support

小气泡.png  A number of patents for probiotic bacteria

小气泡.png  High gastric acid and bile tolerance

小气泡.png  High intestinal activity

LP-LDL is a cholesterol-lowering probiotic developed by CSL (Italy) and the patented OptiBiotx platform (UK). LP-LDL maintains strong metabolic activity under high concentration of bile salts and intestinal acidity, and has improved effects on blood lipids and blood pressure, which are suitable for the elderly and the “three high” populations. Human clinical trials showed that after consumption of yogurt containing LP-LDL, low-density lipoprotein cholesterol decreased by 13.9%, blood lipids (total triglycerides) decreased by 53.9%, and blood pressure (systolic blood pressure) decreased by 5.1%. The strain has obtained 3 registered trademarks and 5 patents, and the patentability is protected globally.

CopyRight2018 bjdoit.com INC. ALL RIGHTS RESERVED.北京多爱特生物科技有限公司 版权所有 京ICP备18002174号-1